Effect of Quyu Shengxin Capsule on Hemorheology and RHS Score of Patients with Early Femoral Head Necrosis

Purpose: Based on the clinical work and related experimental research, this subject is to clarify the influence of Quyu Shengxin Capsule on hemorheology and RHS score of patients with early ONFH through randomized controlled trials, so as to analyze and judge the clinical efficacy of Quyu Shengxin Capsule in treating ONFH, and to study Quyu Shengxin Capsule by analyzing the specific mechanism of action through experiments, so as to provide theoretical basis for clinical application. Forty patients with early ONFH were randomly divided into Quyu Shengxin Capsule group (n=20) and Xianling Gubao Capsule group (n=20). Hemorheological indexes were measured before and after 8 weeks of treatment. Results: After treatment, the hemorheology indexes of the two groups were significantly improved compared with those before treatment, and there were significant differences between the two groups before and after treatment After treatment, the repair and reconstruction (RHS) scores of femoral head necrosis in both groups were significantly higher than those before treatment, and the differences between the two groups before and after treatment were statistically significant (P<0.05). Conclusion: Randomized controlled trials proved that Quyu Shengxin Capsule could significantly improve hemorheology and RHS scores of patients with early ONFH, effectively relieve hip pain and discomfort, improve mobility and joint mobility of patients with ONFH, and improve hemorheology indexes, indicating that Quyu Shengxin Capsule could improve symptoms of patients with ONFH and improve hemorheology indexes of patients with ONFH. Comprehensive embodiment of Quyu Shengxin capsule on early ONFH has a good therapeutic effect.